Women With BRCA1/2 Mutations Have High Risk of Cancer After Age 50

(HealthDay News) — The risk of cancer remains high for women older than 50 years with BRCA1 or BRCA2 mutations, according to a study published in Cancer. Researchers estimated the cumulative risks for all cancers in women from 50 to 75 years of age with a BRCA1 or BRCA2 pathogenic variant. The analysis included 2211 women seen at 85 centers in 16 countries who […]

Read More

Frequent Aspirin Use Reduces Risk For Nonmucinous Ovarian Cancer Regardless Of Genetic Susceptibility

Healio (2/27, Welsh) reported, “Daily or near daily aspirin use reduced the risk for nonmucinous ovarian cancer across most strata of genetic risk based on a polygenic score, according to a case-control study” that “pooled individual-level data from eight population-based case-control studies.” The findings were published in JAMA Network Open. […]

Read More